Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells

Abstract

Preclinical data are reported that support a human immunodeficiency virus (HIV) vaccine strategy using recombinant canarypox–HIV vectors (ALVAC-HIV)